Pharmafile Logo
Pharmafocus logo
Advanced Search

asthma

Showing 15 posts of 82 posts found.

astrazeneca_building_white

AstraZeneca’s Fasenra scores US approval in severe asthma

November 15, 2017
Research and Development, Sales and Marketing AstraZeneca, Fasenra, MedImmune, asthma

AstraZeneca and MedImmune, the company’s biologics research and development division, have revealed the decision by the FDA to approve Fasenra …

News
astrazeneca-sign

AstraZeneca asthma therapy tralokinumab flops at Phase 3

November 1, 2017
Research and Development AstraZeneca, MedImmune, asthma, pharma

AstraZeneca and MedImmune, the company’s global biologics research and development arm, have announced new Phase 3 data revealing that tralokinumab …

News
shutterstock_232245868

Amgen and AstraZeneca’s experimental drug cuts asthma exacerbations by up to 71%

September 7, 2017
Research and Development Amgen, AstraZeneca, MedImmune, asthma, pharma, pharmaceutical, tezepelumab

An anti-TSLP monoclonal antibody jointly developed by Amgen and AstraZeneca’s global biologics and research division, MedImmune, has met its primary …

News
asthma

Asthma drugs reduce Parkinson’s risk by 50%, decade-long study finds

September 5, 2017
Manufacturing and Production, Research and Development Parkinson's, Parkinson's disease, asthma, pharma, pharmaceuticals, salbutamol

A study from the Department of Global Public Health and Primary Care at the University of Bergen (UiB) in Norway …

News
teva_copy

Teva asthma treatment scores NICE approval

July 20, 2017
Sales and Marketing Teva, asthma, biotech, cinqaero, drugs, healthcare, pharma, pharmaceuticals

NICE has reached a decision in its final appraisal determination of Teva’s Cinqaero (reslizumab), recommending the drug’s use as an …

News
shutterstock_232245868

Severe asthma patients require more support, Novartis study suggests

June 19, 2017
Research and Development, Sales and Marketing Novartis, asthma

A new study from Novartis has indicated that patients suffering from severe asthma still do not get adequate support to …

News
astrazeneca_plaque

Strong showing for AZ asthma drug, but diabetes treatment flops

May 23, 2017
Manufacturing and Production, Research and Development AstraZeneca, asthma, diabetes

AstraZeneca has been mulling over mixed news this week after both its severe asthma treatment and diabetes therapy saw varying …

News
lungs

Off-patent cancer drug holds promise for severe asthma treatment

May 18, 2017
Research and Development asthma, imatinib

Researchers from Brigham and Women’s Hospital and Harvard Medical School have conducted a small-scale study into the prospect of using …

News
astrazeneca_building_white

AZ asthma drug falls short in Phase 3 study

May 10, 2017
Research and Development AstraZeneca, asthma, tralokinumab

AstraZeneca and its global biologics research and development arm MedImmune have announced that asthma treatment tralokinumab has failed to achieve …

News
teva_canada

Teva launches competitors to GSK’s Advair inhaler

April 21, 2017
Medical Communications, Sales and Marketing Advair, AirDuo, GSK, Teva, asthma

GSK has been anticipating competition to its Advair for two years and Teva has announced that it will be the …

News
lungs

Asthma drugs may have alternative function as pneumonia treatment

March 1, 2017
Research and Development asthma, influenza, pneumonia

Researchers from the University of Virginia School of Medicine have discovered that two drugs commonly used to treat asthma, Accolate …

News
shutterstock_291014192

NICE recommends GSK’s “first-in-class” asthma drug

November 30, 2016
Sales and Marketing GSK, NICE, Nucala, asthma

NICE has announced its recommendation of GSK’s “first-in-class” biologic Nucala (mepolizumab) as an extra option for the treatment of adults …

News
teva_copy

Teva team up with IBM to tackle two challenges facing the pharma industry

October 27, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cloud Computing, Teva Pharmaceutical, asthma, ibm

Teva Pharmaceuticals and IBM have announced a partnership that will use IBM Watson Health Cloud with the aim of finding …

News
astrazeneca_logo_building

AstraZeneca forced to abandon Phase II trial

October 12, 2016
Research and Development AstraZeneca, Synairgen, asthma, cold, common cold

Synairgen, a respiratory drug discovery and development company, has developed a drug, AZD9412, alongside AstraZeneca to treat and prevent severe …

News
astrazeneca_sign_sky

AZ’s first respiratory biologic meets primary endpoints in Phase III trials

September 5, 2016
Research and Development, Sales and Marketing AstraZeneca, asthma, benralizumab, biologic, respiratory, severe asthma

AstraZeneca has presented Phase III data at the European Respiratory Society (ERS) international congress which shows that trial biologic benralizumab …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025